OrbusNeich Medical Group Holdings Limited (HKG:6929)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.700
+0.010 (0.27%)
Jul 31, 2026, 4:08 PM HKT

HKG:6929 Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
41.939.7245.0718.49-4.44
Depreciation & Amortization
5.764.833.773.53.67
Other Amortization
0.460.470.430.380.35
Loss (Gain) From Sale of Assets
0.10.010.050.030.08
Asset Writedown & Restructuring Costs
-1.57-0.34-
Loss (Gain) From Sale of Investments
0.910.63-0.921.74-0.06
Loss (Gain) on Equity Investments
1.321.510.840.20.21
Stock-Based Compensation
1.021.281.080.681.34
Other Operating Activities
-8.76-13.39-9.352.8222.9
Change in Accounts Receivable
-5.24-5.73-1.74-7.57-1.72
Change in Inventory
-8.06-17.19-6.84-2.5-1.59
Change in Accounts Payable
-3.062.08-2.741.910.84
Change in Other Net Operating Assets
-6.81-2.72-6.623.41-1.08
Operating Cash Flow
19.5313.1123.0323.4320.5
Operating Cash Flow Growth
48.93%-43.06%-1.70%14.31%61.83%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-16.11-9.8-5.6-2.9-1.25
Sale of Property, Plant & Equipment
0.280.070.490.120.22
Cash Acquisitions
-0.78--13.19--
Sale (Purchase) of Intangibles
-2.27-1.42-0.4-0.44-0.89
Investment in Securities
24.367.27-37.77-166.75-3.31
Other Investing Activities
10.4312.534.150.650.01
Investing Cash Flow
15.98.65-52.32-169.32-5.22

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--4.2453.06
Long-Term Debt Issued
----0.23
Total Debt Issued
--4.2453.29
Short-Term Debt Repaid
--4.24--5-42.96
Long-Term Debt Repaid
-2.3-2.11-1.84-1.42-11.71
Total Debt Repaid
-2.3-6.35-1.84-6.42-54.67
Net Debt Issued (Repaid)
-2.3-6.352.4-1.42-51.38
Issuance of Common Stock
--0.1861.64-
Repurchase of Common Stock
-0.31-1.78-0.82--
Common Dividends Paid
-26.55-10.62---
Other Financing Activities
-0.2-0.22-0.88-2.77-1.28
Financing Cash Flow
-29.35-18.960.8857.44146.31

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.33-1.390.01-0.8-0.81
Net Cash Flow
6.421.41-28.39-89.24160.77

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
3.423.3217.4320.5319.25
Free Cash Flow Growth
3.02%-80.97%-15.11%6.66%64.22%
Free Cash Flow Margin
1.89%2.02%11.33%15.01%16.53%
Free Cash Flow Per Share
0.000.000.020.030.03
Levered Free Cash Flow
-3.63-4.255.3215.5612.32
Unlevered Free Cash Flow
-3.52-4.125.4116.4715.83

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.20.220.140.130.75
Cash Income Tax Paid
5.616.633.61.981.85
Change in Working Capital
-23.17-23.55-17.94-4.75-3.54